Hypogonadotropic Hypogonadism/Kallmann Syndrome Panel

Clinical Use

Use

This test is designed for individuals who have relevant features or a clinical or suspected diagnosis of hypogonadotropic hypogonadism or Kallmann syndrome. It is particularly useful for those experiencing absent or incomplete puberty accompanied by low levels of gonadotropins such as LH and FSH.

Special Instructions

Not provided.

Limitations

This test is developed and validated by PreventionGenetics following CAP and CLIA regulations but is not cleared or approved by the FDA. It combines NGS sequencing with CNV analysis but may not detect all genetic alterations. Results should be interpreted in the context of clinical symptoms and other laboratory findings.

Test Details

New York Approved